Key Highlights
- Ginkgo Bioworks releases first proprietary protein LLM, trained on exclusive datasets.
- Collaboration with Google Cloud enables AI-driven drug discovery tools.
- Open API allows researchers to access Ginkgo’s machine learning models affordably.
- Chris Sakalosky, Google Cloud praises Ginkgo for democratizing AI tools in life sciences.
Source: Business Wire
Notable Quotes
- “We believe that the low cost for tokens and our customer-friendly terms will allow users to build innovative tools and applications.” — Jason Kelly, CEO at Ginkgo Bioworks
- “Ginkgo’s new protein LLM and open API mark a major step forward in making advanced AI tools accessible for drug discovery.” — Chris Sakalosky, VP of Strategic Industries at Google Cloud
- “Our API comes with competitive pricing and a free tier, empowering users to experiment without high fees.” — Ankit Gupta, General Manager at Ginkgo AI
SoHC's Take
This launch marks a significant milestone in the biotech industry, merging cutting-edge AI with biological research. By partnering with Google Cloud, Ginkgo Bioworks is unlocking new potential for drug discovery and biotechnology innovation. The release of a proprietary protein LLM and an open API demonstrates Ginkgo’s commitment to making advanced research tools more accessible and affordable, a game-changer for pharmaceutical and biotech industries looking to streamline and scale their R&D efforts. The user-friendly pricing model further ensures that even smaller entities can benefit from these sophisticated technologies.
Heading
Key Highlights Shore Capital Partners launches Agentis Longevity to lead the longevity healthcare sector. Jimmy St Louis named CEO, bringing expertise from Regenerative Medicine ...
Key Highlights Nymbl Systems announces strategic partnership with Frontier Growth to accelerate growth and innovation. Frontier Growth brings 25+ years of growth equity expertise to ...
Key Highlights Launch of fingertip blood collection technology using BD’s MiniDraw™ and Babson’s BetterWay for U.S. health systems. Revolutionizes access with fewer ...
Key Highlights Anatomy Financial raises $19M in Series A funding, led by Canapi Ventures. Neil Underwood (Canapi) and Nicole Quinn ...
Key Highlights Wendy Barnes to assume role as GoodRx CEO on January 1, 2025. Brings 30+ years of leadership in pharmacy and healthcare benefit industries. Former CEO of RxBenefits and President of Express ...
Key Highlights Mike Butler, former Providence president, joins Linus Health's board of directors. Butler brings decades of healthcare leadership and ...
